Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial

Research projects

  1. ACCOST: Adrecizumab in Cardiogenic Shock

    Karakas, M., Karakas, M. & Sehner, S.

    01.03.1931.12.27

    Project: Research